Biotech Financing Report
Biotech Financing Summary
The Biotech Financing Summary a quarterly report produced by Venture Valuation using data taken from Biotechgate. It provides an overview of recent financing activities in the biotechnology and digital health fields.
Designed for business development teams, investors, life science executives and consultants, the report highlights key funding trends and helps readers understand where capital is flowing across the life sciences industry.
You can download the free version of the latest report below. For access to the full report as well as previous editions, you need a subscription to Biotechgate.
Latest Biotech Financing Insights
The latest edition of the Biotech Financing Summary provides a structured overview of recent biotech financing activity, including private financing rounds, IPOs, regional funding trends and leading companies by amount raised.
The report helps answer questions such as:
• Which biotechs raised the most capital?
• Which regions attracted the highest levels of financing?
• How are financing trends changing quarter by quarter?
What’s Included in the Report?
The free Biotech Financing Summary includes selected insights and charts covering:
• Global biotech and life sciences financing activity
• Private financing trends by region
• Financing rounds by size and stage
• Sector-level financing activity
• Selected top private fundraisers
• IPO trends in the life sciences industry
Why Use Biotechgate for Financing Intelligence?
Biotechgate provides comprehensive life sciences data for business development, licensing, and competitive intelligence teams. The database includes company profiles, management contacts, financing rounds, investors, licensing agreements, M&A transactions and assets.
The Biotech Financing Summary is based on this data and gives readers a practical snapshot of current financing activity in the global life sciences industry.